Higher plasma soluble Receptor for Advanced Glycation End Products (sRAGE) levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study (Q34024272)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Higher plasma soluble Receptor for Advanced Glycation End Products (sRAGE) levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

30 July 2017

Higher plasma soluble Receptor for Advanced Glycation End Products (sRAGE) levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study (English)

1 reference

Europe PubMed Central

30 July 2017

type-1 diabetes

0 references

cardiovascular disease

1 reference

based on heuristic

inferred from title

8

object named as

Peter Rossing

0 references

Isabel C. F. R. Ferreira

3

object named as

Isabel Ferreira

1 reference

Europe PubMed Central

30 July 2017

object named as

Anders Jorsal

2

0 references

Coenraad Dirk Adriaan Stehouwer

9

object named as

Coen D A Stehouwer

1 reference

Europe PubMed Central

30 July 2017

Casper G. Schalkwijk

4

object named as

Casper G Schalkwijk

1 reference

Europe PubMed Central

30 July 2017

author name string

Johanna W M Nin

1

1 reference

Europe PubMed Central

30 July 2017

Martin H Prins

5

1 reference

Europe PubMed Central

30 July 2017

Hans-Henrik Parving

6

1 reference

Europe PubMed Central

30 July 2017

Lise Tarnow

7

1 reference

Europe PubMed Central

30 July 2017

language of work or name

0 references

publication date

3 June 2010

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

59

1 reference

Europe PubMed Central

30 July 2017

2027-2032

1 reference

Europe PubMed Central

30 July 2017

8

1 reference

Europe PubMed Central

30 July 2017

copyright license

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

27 August 2021

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Decreased serum esRAGE level is associated with angiographically determined coronary plaque progression in diabetic patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2911054

5 July 2018

RAGE: a novel biological and genetic marker for vascular disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2911054

5 July 2018

Advanced glycation end products and their circulating receptors and level of kidney function in older community-dwelling women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2911054

5 July 2018

Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2911054

5 July 2018

Serum levels of sRAGE, the soluble form of receptor for advanced glycation end products, are associated with inflammatory markers in patients with type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2911054

5 July 2018

Improved prognosis in type 1 diabetic patients with nephropathy: a prospective follow-up study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2911054

5 July 2018

Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2911054

5 July 2018

N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2911054

5 July 2018

Increased glycated albumin and decreased esRAGE levels are related to angiographic severity and extent of coronary artery disease in patients with type 2 diabetes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2911054

29 October 2018

Serum endogenous secretory RAGE level is an independent risk factor for the progression of carotid atherosclerosis in type 1 diabetes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2911054

29 October 2018

Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2911054

29 October 2018

Soluble RAGE but not endogenous secretory RAGE is associated with albuminuria in patients with type 2 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2911054

29 October 2018

Elevation of soluble form of receptor for advanced glycation end products (sRAGE) in diabetic subjects with coronary artery disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2911054

29 October 2018

Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2911054

29 October 2018

The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2911054

29 October 2018

RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2911054

29 October 2018

Decreased endogenous secretory advanced glycation end product receptor in type 1 diabetic patients: its possible association with diabetic vascular complications

1 reference

https://pubmed.ncbi.nlm.nih.gov/20522598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20522598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Markers of Endothelial Dysfunction and Inflammation in Type 1 Diabetic Patients With or Without Diabetic Nephropathy Followed for 10 Years: Association with mortality and decline of glomerular filtration rate

1 reference

https://pubmed.ncbi.nlm.nih.gov/20522598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endogenous secretory RAGE but not soluble RAGE is associated with carotid atherosclerosis in type 1 diabetes patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20522598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)

1 reference

https://pubmed.ncbi.nlm.nih.gov/20522598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Levels of soluble receptor for AGE are cross-sectionally associated with cardiovascular disease in type 1 diabetes, and this association is partially mediated by endothelial and renal dysfunction and by low-grade inflammation: the EURODIAB Prospectiv

1 reference

https://pubmed.ncbi.nlm.nih.gov/20522598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased serum HMGB1 level is associated with coronary artery disease in nondiabetic and type 2 diabetic patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20522598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Advanced Glycation End Products Activate Endothelium Through Signal-Transduction Receptor RAGE

1 reference

https://pubmed.ncbi.nlm.nih.gov/20522598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2337/DB09-1509

1 reference

Europe PubMed Central

30 July 2017

Internet Archive ID

pubmed-PMC2911054

0 references

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34024272&oldid=1973969289"